DANA MEHRING: Open Payments
NPI 1336709468 · KENOSHA, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$862 in 22 payments from 8 companies in 2025. Trend: 2023 $145 · 2024 $27 · 2025 $862
Food & beverage: $862
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 6 | $300 |
| Gilead Sciences, Inc. | 3 | $148 |
| Lilly USA, LLC | 2 | $143 |
| Indivior Inc. | 5 | $132 |
| Alkermes, Inc. | 2 | $51 |
| Braeburn Inc. | 2 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
Products named: Auvelity, SUBLOCADE, Epclusa, ZEPBOUND, VIVITROL, BRIXADI, TRINTELLIX, INGREZZA.
Industry payments across WI — which companies pay providers there.
